Prognostic value of perfusion-FDG mismatch in ischemic cardiomyopathy

Journal of Nuclear Cardiology

Volumn 9, Issue 6, 2002, Pages 675-677

  Bax, Jeroen J ^a   Visser, Frans C ^b   Poldermans, Don ^c   Elhendy, Abdou ^c   Boersma, Eric ^c   Visser, Cees A ^b   Roelandt, Jos R T C ^c  

^a LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^b VU UNIVERSITY MEDICAL CENTER   (Netherlands)

^c ERASMUS MEDICAL CENTER   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; FLUORODEOXYGLUCOSE; NITRIC ACID DERIVATIVE; ORAL ANTIDIABETIC AGENT; SPIRONOLACTONE;

AGED; ANGINA PECTORIS; CARDIOMYOPATHY; CARDIOVASCULAR RISK; CASE REPORT; DISEASE COURSE; ECHOCARDIOGRAPHY; HEART EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART MUSCLE ISCHEMIA; HEART TRANSPLANTATION; HUMAN; INTERMETHOD COMPARISON; MALE; NON INSULIN DEPENDENT DIABETES MELLITUS; NOTE; PRIORITY JOURNAL; PROGNOSIS; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; SUDDEN DEATH;

EID: 0036868734     PISSN: 10713581     EISSN: None     Source Type: Journal    
DOI: 10.1067/mnc.2002.125218     Document Type: Article

References (3)

1. Beller GA. Selecting patients with ischemic cardiomyopathy for medical treatment, revascularization, or heart transplantation. J Nucl Cardiol 1997;4:152-7.
2. Haas F, Haehnel CJ, Picker W, et al. Preoperative positron emission tomographic viability assessment and perioperative and postoperative risk in patients with advanced ischemic heart disease. J Am Coll Cardiol 1997;30:1693-700.
3. Iskander S, Iskandrian AE. Prognostic utility of myocardial viability assessment. Am J Cardiol 1999;83:694-702.